Acute Coronary Syndromes - APAC Analysis and Market Forecasts

1
Acute Coronary Syndromes - APAC Analysis and
Market Forecasts
One-Stop Shop for Business Information
2
Summary
The ACS in vitro diagnostics market is dominated
by a single biomarker test, cardiac troponins.
However, this market remains of high interest due
to advancements in assay sensitivity both on
laboratory and point-of-care platforms.
GlobalData expects these advancements to have an
impact on other diagnostic tests such as creatine
kinase-MB isoenzyme and myoglobin. Furthermore,
the emergence of pipeline biomarker tests will
change the landscape of ACS in vitro diagnostic
testing and is expected to provide enhancements
in the early diagnosis of the disease. Acute
coronary syndrome (ACS) consists of two major
diseases, myocardial infarction (MI) and unstable
angina, with the former being one of the major
killers in the mature markets. Though the
incidence of ACS is either in decline or steady
across the US and European countries,
3

• millions of ACS and suspected ACS patients still
  visit emergency rooms every year with symptoms
  such as chest pain, and these patients are
  typically assessed with in vitro diagnostic
  cardiac biomarker tests. The ACS diagnostic
  cardiac biomarker reagents market is dominated by
  the cardiac troponins, the gold-standard
  biomarkers for the diagnosis of MI.Scope
• An overview of ACS, which includes epidemiology,
  etiology, symptoms, diagnosis, pathology and
  treatment guidelines.
• Annualized APAC ACS in vitro diagnostic testing
  reagents market revenue and future forecasts from
  2009 to 2011, forecast for 7 years to 2018.-
  Investigation of current and future market
  competition for diagnostic cardiac biomarkers for
  ACS
• - Insightful review of the key industry drivers,
  restraints and challenges as well as predicted
  impact of key events.

4

• Competitor assessment including device approval
  analysis and device sales forecasts.
• Marketed and pipeline product profiles covering
  efficiency, safety, clinical study details,
  device approvals, product positioning and device
  sales forecast.
• Analysis of unmet needs within the market and
  opportunities for future players.
• Technology trends evaluation to assess strength
  of pipeline.- An overview of all devices in
  development including clinical study details,
  design and material selection considerations,
  efficacy reports, and device approval timelines.
• Company profiles including business description,
  financial overview and SWOT analysis.
• Coverage of key market players.

5

• Strategic assessment of the diagnostic cardiac
  biomarkers for ACS sector through market impact
  analysis, future market scenario and company
  analysis.
• Direct quotes from Key Opinion Leaders (KOL) as
  well as cardiologists
• Reasons to buy
• Understand the trends shaping and driving APAC
  diagnostic cardiac biomarkers for ACS.
• Realize device preferences of physicians who have
  performed the tests already.
• Access market sizing, forecasts and quantified
  growth opportunities in APAC diagnostic cardiac
  biomarkers for ACS Market through 2018.-
  Quantify candidate patient populations to better
  design product pricing launch plans.

6

• Drive revenues, formulate effective sales and
  marketing strategies and gain in-depth
  understanding of the competitive landscape.
• Perform benchmarking analysis of growth
  opportunities against currently marketed
  products.
• Assess competitiveness of products in market by
  understanding the strengths and weaknesses of
  current competition.
• Take a comprehensive look at the markets device
  pipeline and identify promising,
  paradigm-shifting products.
• Create an effective counter-strategy to gain a
  competitive advantage against those currently in
  the market.
• - Organize your sales and marketing efforts by
  identifying the market categories and segments
  that present the best opportunities for growth.-
  Whats the next big thing in APAC diagnostic
  cardiac biomarkers for ACS market landscape?
  Identify, understand and capitalize.

7
Table Of Content

1. Table of Contents
2. INTRODUCTION
3. Disease Overview
4. Competitive Assessment
5. Unmet Needs
6. Pipeline Products
7. Industry Overview
8. Current and Future Players
9. Market Drivers and Opportunities and Barriers
10. Country Outlooks and Forecasts
11. Appendix

8

• To know more
• Acute Coronary Syndromes - APAC Analysis and
  Market Forecasts

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com